UK Pharma Wins Tariff Exemption in US Trade Deal, Faces Broader Import Challenges Under Trump Agreements episode artwork

EPISODE · Dec 17, 2025 · 2 MIN

UK Pharma Wins Tariff Exemption in US Trade Deal, Faces Broader Import Challenges Under Trump Agreements

from United Kingdom Tariff News and Tracker · host Inception Point AI

Welcome to United Kingdom Tariff News and Tracker, your essential guide to the latest US trade developments affecting UK businesses under President Trump. In a major win for the UK life sciences sector, the US and UK have struck a landmark agreement in principle on pharmaceuticals and medtech, as detailed by Mills & Reeve and AFS Law. UK-origin medicines, pharmaceutical ingredients, and medical technology are now exempt from US tariffs for at least three years, shielding them from Section 232 duties. In exchange, the UK commits to boosting spending on innovative treatments by 25%, with NICE raising its cost-effectiveness threshold from £20,000-£30,000 to £25,000-£35,000 per QALY gained. This could greenlight 3-5 more new medicines annually. Plus, the Voluntary Scheme for Branded Medicines Pricing and Access payment rate drops to 14.5% in 2026 from 22.9% in 2025, easing pressures on pharma firms. Broader tariffs pose challenges, though. The Manufacturer reports the UK faces a general 10% US tariff on imports, part of Trump's sweeping hikes now averaging 17.9% per Yale's Budget Lab analysis cited by Freiheit.org. EY Tax News notes some tariffs start at zero percent on January 1, 2026, rising to 10% in 2027 and 15% in 2028. AFS Law highlights exemptions for UK pharma amid Section 301 extensions through November 2026, but UK exporters must navigate rising shipping and customs costs, as warned by Power Forwarding. A snag: Alliance News reports the US has suspended implementation of a UK tech cooperation deal on December 16, signaling tensions in other sectors. These moves stem from the May 2025 UK-US Economic Prosperity Deal, balancing tariff relief with pricing reforms. UK firms in pharma and medtech gain a lifeline, but manufacturers watch general rates warily amid Trump's reciprocal tariff push. Thanks for tuning in, listeners—subscribe now for weekly updates to stay ahead. This has been a Quiet Please production, for more check out quietplease.ai. For more check out https://www.quietperiodplease.com/ Avoid ths tariff fee's and check out these deals https://amzn.to/4iaM94Q This content was created in partnership and with the help of Artificial Intelligence AI.

Episode metadata supplied by the publisher feed · Published Dec 17, 2025

Embed this episode

NOW PLAYING

UK Pharma Wins Tariff Exemption in US Trade Deal, Faces Broader Import Challenges Under Trump Agreements

0:00 2:25

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of United Kingdom Tariff News and Tracker?

This episode is 2 minutes long.

When was this United Kingdom Tariff News and Tracker episode published?

This episode was published on December 17, 2025.

Is there a transcript available for this episode?

Yes, a full transcript is available for this episode. You can read the complete transcript on the episode page.

Can I download this United Kingdom Tariff News and Tracker episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!